Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00876915
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolism
Intervention: Drug: dalteparin injection

Indicates status has not been verified in more than two years